Track Order   | Customer Support   | Request Book   |
International Order
Pancreatic Cancer An Issue of Hematology Oncology Clinics of North America 1st Edition at Meripustak

Pancreatic Cancer An Issue of Hematology Oncology Clinics of North America 1st Edition

Books from same Author: Wolpin, Brian

Books from same Publisher: Elseiver

Related Category: Author List / Publisher List

  • Retail Price: ₹ 8929/- [ 5.00% off ]

    Seller Price: ₹ 8482

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available


Click for International Orders
  • Provide Fastest Delivery
  • 100% Original Guaranteed
    • General Information  
    Author(s)Wolpin, Brian
    PublisherElseiver
    Edition1st Edition
    ISBN9780323393362
    LanguageEnglish
    Publish YearAugust 2015

    Description

    Elseiver Pancreatic Cancer An Issue of Hematology Oncology Clinics of North America 1st Edition by Wolpin, Brian

    This issue of Hematology/Oncology Clinics of North America is devoted to Pancreatic Cancer. Guest Editor Brian Wolpin, MD has assembled a group of expert authors to review the following topics: Biology and genetics of pancreatic adenocarcinoma; Mouse models of pancreatic adenocarcinoma; Epidemiology and inherited predisposition for sporadic pancreatic adenocarcinoma; Familial pancreatic adenocarcinoma; Imaging and endoscopic approaches to pancreatic cancer; Diagnosis and management of pancreatic cystic neoplasms; Surgical management of pancreatic cancer; Peri-operative therapy for surgically resectable pancreatic adenocarcinoma; Diagnosis and management of borderline resectable pancreatic adenocarcinoma; Treatment approaches to locally advanced pancreatic adenocarcinoma; Therapeutic approaches for metastatic pancreatic adenocarcinoma; Supportive and end-of-life care for patients with pancreatic adenocarcinoma; and Novel therapeutics for pancreatic adenocarcinoma._x000D_